Contingency Management Using Smartphone App in Patients With SUD

NCT04162132 | Completed

• 1 other identifier: 7135-SRyan
• Study Type: observational
• Target: 108
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this research study is to test the acceptance and efficacy of a smartphone app (DynamiCare Rewards) for patients with substance use disorder (SUD) who are in active treatment and recovery at BrightView.

Conditions

Substance Use Disorders

Keywords

contingency management; smartphone app; substance use disorder; outpatient addiction treatment; BrightView; DynamiCare

Outcome Measures

Primary Outcomes (3)

• Attendance

  The DynamiCare smart phone app was used to see whether the percentage of scheduled appointments could be increased by using the app. As measured by % of attendance of medical and clinical appointments compared to controls.

  4 months

• Substance Use

  The DynamiCare smart phone app was used to see if use of the app could reduce substance use as measured by urine toxicology results. Measured percentage of patients using the app testing consistent only for prescribed substances in random clinical urine tests compared to controls.

  4 months

• Retention

  The DynamiCare smart phone app was used to see if treatment retention could be increased when the app was added to treatment as usual. Measured as the percent of patients who are still active in the DynamiCare app and attending treatment sessions after 1, 2, 3, and 4 months compared to controls.

  4 months

Study Arms (2)

DynamiCare group

Patients at Morgan Street location of BrightView who were given the DynamiCare smartphone app.

Device: Smartphone app

Non-DynamiCare group

Patients at Colerain location of BrightView who were not given the DynamiCare smartphone app.

Interventions

Smartphone app DEVICE

Study procedures related to the DynamiCare Rewards intervention were conducted via smartphone. Research visits included collection of urine samples and medical exams. Participants assigned to the DynamiCare Rewards group received: 1) the app on their smartphone, 2) drug testing devices when indicated (pocket-sized breathalyzer), and a reloadable debit card for receiving the financial incentives (the PEX debit card). Global Positioning System (GPS) tracking was used to track whether patients had attended their scheduled appointments but was not used at any other times. All information was uploaded from the app onto the DynamiCare Analytics website, which treatment providers could view. The information reported was: attendance status of appointments, the status of all alcohol and drug testing, and incentives earned. Each patient's intervention period (period of time when they used the app) lasted four months from the date of their enrollment.

DynamiCare group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study focused on a population of 108 adult patients with a primary diagnosis of substance use disorder who were enrolled at a BrightView outpatient treatment center.

You may qualify if:

• \>18 years old
• Substance use disorder (SUD) as a primary diagnosis
• Have and use an Android or iOS smartphone with acceptable capability
• Are willing to participate in home testing and use of the smartphone
• Speak and read the English language adequately to understand smartphone commands and responses
• Are willing to be randomly assigned to receive treatment with or without the smartphone app as an added feature.

You may not qualify if:

• N/A

Sponsors & Collaborators

• BrightView LLC: lead
• DynamiCare Health: collaborator

Study Sites (1)

BrightView

Cincinnati, Ohio, 45206, United States

Location

Related Links

• BrightView -- Outpatient addiction treatment center conducting the study
• DynamiCare Health -- Maker of the smartphone app used in the study

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders

Study Officials

• Shawn Ryan, MD, MBA

  President & CMO

  PRINCIPAL INVESTIGATOR

• Samin Rezania, PhD

  Director of Clinical Research

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 25, 2019
• First Posted: November 14, 2019
• Study Start: January 25, 2019
• Primary Completion: July 29, 2019
• Study Completion: July 29, 2019
• Last Updated: November 20, 2019

Record last verified: 2019-11

Locations

US (1)